Great progress in cancer drug development and approvals but still incredible unmet need.


In the 1980s, only 4% of new drugs approved by the FDA were cancer treatments. But since 2010, cancer drugs have claimed 27% of new approvals—a share that doubled over the previous decade—according to a new report from the Tufts Center for the Study of Drug Development.


Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

info@oncologystrategies.com   |   Overland Park, KS 66223

  • Facebook Basic Black
  • Twitter Basic Black
  • Black Instagram Icon